22 May 2013
Keywords: imclone, pay, repligen, 65m, erbitux, case, biopharmaceutical
Article | 17 September 2007
Biopharmaceutical firm Repligen has reached a settlement in its law suit against fellow US firm ImClone, which alleged that the ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
17 September 2007
10 September 2007
21 May 2013
© 2013 thepharmaletter.com